TP53 and cervical carcinoma: In a subgroup analysis conducted by adjustment, we found that TP53 rs1042522 polymorphism was associated with an increased susceptibility to cervical cancer in covariates-adjusted studies in two models (GG + GC vs CC: OR = 3.167, 95% CI: 1.934-5.185; GG vs CC: OR = 2.509, 95% CI: 1.465-4.298, 95% PI: 0.317-19.843).